These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15044039

  • 1. Role of dopamine D1 receptors in the striatal and cortical fos expression induced by the muscarinic agonist pilocarpine.
    Wirtshafter D.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):85-90. PubMed ID: 15044039
    [Abstract] [Full Text] [Related]

  • 2. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
    Lee J, Rushlow WJ, Rajakumar N.
    Neuroscience; 2007 Nov 09; 149(3):602-16. PubMed ID: 17913375
    [Abstract] [Full Text] [Related]

  • 3. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 4. The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression.
    Wirtshafter D.
    Brain Res; 2006 Apr 26; 1085(1):127-31. PubMed ID: 16564505
    [Abstract] [Full Text] [Related]

  • 5. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.
    Steiner H, Gerfen CR.
    J Comp Neurol; 1995 Mar 06; 353(2):200-12. PubMed ID: 7745131
    [Abstract] [Full Text] [Related]

  • 6. Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats.
    Morelli M, Pinna A, Fenu S, Carta A, Cozzolino A, Di Chiara G.
    Synapse; 1994 Dec 06; 18(4):288-93. PubMed ID: 7886620
    [Abstract] [Full Text] [Related]

  • 7. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 8. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS, Mabrouk OS, Pehek EA.
    J Pharmacol Exp Ther; 2004 Oct 12; 311(1):342-8. PubMed ID: 15175419
    [Abstract] [Full Text] [Related]

  • 9. D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration.
    Muller DL, Unterwald EM.
    J Pharmacol Exp Ther; 2005 Jul 12; 314(1):148-54. PubMed ID: 15772255
    [Abstract] [Full Text] [Related]

  • 10. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain.
    Blandini F, Fancellu R, Orzi F, Conti G, Greco R, Tassorelli C, Nappi G.
    Neurol Sci; 2002 Sep 12; 23 Suppl 2():S57-8. PubMed ID: 12548342
    [Abstract] [Full Text] [Related]

  • 11. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
    Mayorga AJ, Trevitt JT, Conlan A, Gianutsos G, Salamone JD.
    Psychopharmacology (Berl); 1999 Mar 12; 143(1):72-81. PubMed ID: 10227082
    [Abstract] [Full Text] [Related]

  • 12. Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice.
    Benturquia N, Courtin C, Noble F, Marie-Claire C.
    Brain Res; 2008 May 23; 1211():1-5. PubMed ID: 18433738
    [Abstract] [Full Text] [Related]

  • 13. D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja.
    Wirtshafter D.
    Synapse; 1998 Feb 23; 28(2):154-9. PubMed ID: 9450515
    [Abstract] [Full Text] [Related]

  • 14. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
    Isacson R, Kull B, Wahlestedt C, Salmi P.
    Neuroscience; 2004 Feb 23; 124(1):33-42. PubMed ID: 14960337
    [Abstract] [Full Text] [Related]

  • 15. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
    Jones CK, Eberle EL, Shaw DB, McKinzie DL, Shannon HE.
    J Pharmacol Exp Ther; 2005 Mar 23; 312(3):1055-63. PubMed ID: 15574685
    [Abstract] [Full Text] [Related]

  • 16. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE, Hart JC, Bymaster FP, Calligaro DO, DeLapp NW, Mitch CH, Ward JS, Fink-Jensen A, Sauerberg P, Jeppesen L, Sheardown MJ, Swedberg MD.
    J Pharmacol Exp Ther; 1999 Aug 23; 290(2):901-7. PubMed ID: 10411607
    [Abstract] [Full Text] [Related]

  • 17. Muscarinic receptor blockade attenuates reserpine-mediated Fos induction in the rat striatopallidal pathway.
    Pollack AE, Angerer MR.
    Brain Res; 2005 Oct 05; 1058(1-2):189-92. PubMed ID: 16153612
    [Abstract] [Full Text] [Related]

  • 18. Expression of c-fos protein in the experimental epilepsy induced by pilocarpine.
    Barone P, Morelli M, Cicarelli G, Cozzolino A, DeJoanna G, Campanella G, DiChiara G.
    Synapse; 1993 May 05; 14(1):1-9. PubMed ID: 8511714
    [Abstract] [Full Text] [Related]

  • 19. Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.
    Zornoza T, Cano-Cebrián MJ, Martínez-García F, Polache A, Granero L.
    Neuropharmacology; 2005 Dec 05; 49(7):1067-76. PubMed ID: 16040065
    [Abstract] [Full Text] [Related]

  • 20. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J, Dougherty JJ, Nichols RA.
    J Neurochem; 2006 Jul 05; 98(2):481-94. PubMed ID: 16805841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.